Alza Corporation

Other

Ez Environmental Solutions

Alza Corporatiton

Vincent Joseph Ferrari

Liang C Dong

Patrick S-l Wong

Patrick S Wong

Jeffrey Wayne Etter

James Horvath

David E Edgren

Nathan Roth

Patrick S L Wong

Crystal Pollock

Andrew I Poutiatine

Miriam A Martin

Christopher M Ohms

Liang-Chang Dong

Joyce C Anthony

Christopher M G Ohms

Stephen S Hwang

Felix T Theeuwes

Jeri D Wright

Steven D Larsen

Michael D Damron

Steven Espinal

Patrick S -l Wong

Neil J Bailer

Nhan Nguyen Thanh Lam

Scott A Comiso

Radomir N M Vukadin

Keru O Shafi

Ted Smith

Radomir N Vukadin

The present invention is directed to a closure system for an oral active agent delivery device. The device comprises an elongate tubular member having first and second ends. The closure system includes a deformable closure means adapted to allow delivery of the active agent upon deformation. The closure system prevents spillage and maintains the integrity of the dose within the device. In use, the closure system is deformed and separated from the second end of the tubular member, liquid is drawn up into the first end of the member, and the liquid and active agent are drawn out of the second end of the member and into the patient's mouth.

Closure system for an active agent delivert device

The present invention is directed to a mixing system for an active agent delivery device. The device comprises an elongate tubular member having first and second ends and a mixing system. The mixing system enables the entire dose of active agent to be entrained in a liquid. In use, liquid is drawn into the first end of the device, the mixing system mixes the liquid and active agent within the device and the active agent entrained in the liquid is drawn out of the second end of the member and into the patient's mouth.

Mixing system for an active agent delivery device

A dosage form is disclosed comprising a semipermeable walled container that houses a capsule, which capsule comprises a drug formulation, a piston, and an osmotic composition. The dosage form delivers the drug formulation through a passageway at a controlled rate over a sustained-release period of time up to 24 hours.

Dosage form comprising therapeutic formulation

The present invention is directed to an active agent dosage that is useful for the prolonged delivery of an active agent formulation to fluid environment of use. The active agent dosage form is a matrix that has an insoluble material circumscribing a portion of the surface of the matrix. The invention is also directed to a method of making the active agent dosage form.

Banded prolonged release active agent dosage form

A phosphatizing system for phosphatizing an object including a closed-loop phosphatizing assembly is provided configured to pass a phosphatizing reagent solution over an object during a phosphatizing procedure. The phosphatizing assembly includes a collection compartment in fluid communication with a run-off portion of a subfloor assembly supporting the object for receipt of substantially all the reagent run-off fluids from the subfloor assembly. A storage assembly is configured to pass a rinsing solution over the object to wash the reagent solution therefrom during a finishing rinse procedure performed after the phosphatizing procedure. This storage assembly includes a storage compartment in fluid communication with the run-off portion for receipt of substantially all the rinsing/reagent run-off fluids from the subfloor assembly. A fill pump, in fluid communication between the collection compartment and the storage compartment, is provided to transfer rinsing/reagent run-off fluids collected in the storage compartment to the collection compartment when the reagent solution contained therein drops below a predetermined operational fluid level.

Closed-loop phosphatizing system and method

Oral active agent delivery system having improved flow controllers. A hollow tubular member containing the active agent formulation and having a fluid passing controller is placed at one end into a fluid and at a second end into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.

Flow controller configurations for an active agent delivery device

A dosage form is disclosed comprising a wall that defines an injection-molded compartment housing a capsule comprising a drug formulation.

Dosage form comprising a capsule

Polymeric compositions are disclosed comprising a poly(caprolactone), a poly(alkylene oxide), a poly(oxyethylenated fatty acid ester), or a poly(oxyethylenated fatty acid), or a poly(oxyethylene-co-oxypropylene).

Injection-moldable composition and article of manufacture comprising same

The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.

Closure system for an active agent delivery device

The present invention is directed to an active agent dosage form that is useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a matrix that has an insoluble material circumscribing a portion of the surface of the matrix. The invention is also directed to a method of making the active agent dosage form.

The present invention is directed to an oral active agent delivery system and method for delivering discrete units of an active agent to a patient. An elongate tubular member having first and second ends comprises first and second flow paths. Either or both of said flow paths contains an active agent. Liquid is drawn up into the first end of the member, and the liquid and active agent is drawn out of the second end of the member and into the patient's mouth.

Multiple flow path device for oral delivery of discrete units

A dosage form is disclosed comprising an injection-molded housing member free of organic solvents.

Growing community of inventors

Foster City, CA, United States of America

Vincent Joseph Ferrari